| Issue Date | Title | Author(s) | Type | Мp-cat. |
| 2020 | Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure | Seferović, Petar M.  ; ...; Polovina, Marija M.  ; ...; Seferović, Jelena P. ; ...; (broj koautora 37) | Article | |
| 2020 | The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians | Anker, Markus S; ...; Milinkovic, Ivan M; ...; Seferovic, Petar M ; (broj, koautora 24) | Article | |
| 2020 | Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology | Chioncel, Ovidiu; ...; Seferovic, Petar M | Article | |
| 2020 | Which parameters of myocardial deformation are useful for clinical presentation of patients with acute myocarditis with middle range or preserved ejection fraction | Krljanac, Gordana ; Veljić, Ivana ; Ristić, Arsen ; Maksimović, Ružica ; Ašanin, Milika ; Polovina, Marija ; Milinković, Ivan ; Nedeljković-Arsenović, Olga ; Seferović, Petar | Conference Paper | |
| 2020 | Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology | Harjola, Veli-Pekka; ...; Seferovic, Petar M ; ...; (broj, koautora 36) | Article | |
| 2020 | Practice makes perfect: improved long-term survival in non-ischaemic dilated cardiomyopathy with contemporary treatment | Seferović, Petar M. ; Ašanin, Milika R ; Polovina, Marija M. | Article | |
| 2020 | Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardio | Lyon, Alexander R; ...; Seferovic, Petar M ; ...; (broj, koautora 52) | Article | |
| 2020 | Non-insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials | Savarese, Gianluigi; Schrage, Benedikt; Cosentino, Francesco; Lund, Lars H; Rosano, Giuseppe MC; Seferovic, Petar M ; Butler, Javed | Article | |
| 2020 | Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome | Bittner, Vera A.; ...; Dilić, Mirza; ...; Ristić, Arsen D. ; ...; Simić, Dragan V. ; Ivanović, Nikola; Davidović, Goran T. ; Tasić, Nebojša M.;
Ašanin, Milika R. ; Stojić, Stevo; Apostolović, Svetlana R. ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Aranđelović, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V. ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1378); | Article | |
| 2020 | Clinical Practice Guides ESC 2019 guide on diabetes, prediabetes and cardiovascular disease, in collaboration with the European Association for the Study of Diabetes (EASD) | Cosentino, Francesco; ...; Seferovic, Petar M ; ...; (broj, koautora 24) | Article | |
| 2020 | Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from theCardio-Oncology Study Groupof theHeart Failure Associationand theCardio-Oncology Council of the European Society of Cardiology | Pudil, Radek; ...; Seferovic, Petar M ; ...; (broj, koautora 37) | Article | |
| 2020 | In search of a 'safety zone' for glycaemic control: association betweenglycosylated haemoglobinlevels and outcomes in patients with type 2 diabetes and cardiovascular disease | Seferović, Petar M. ; Polovina, Marija M. | Other | |
| 2020 | Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry | Rossignol, Patrick; ...; Seferovic, Petar M ; ...; (broj, koautora 18) | Article | |
| 2020 | The utility of left ventricle deformation in patients with myocarditis with midle-range and preserved ejection fraction | Krljanac, Gordana V. ; Veljić, Ivana ; Ristić, Arsen ; Maksimović, Ružica ; Milinković, Ivan ; Ašanin, Milika ; Stanisavljević, Dejana ; Polovina, Marija ; Seferović, Petar | Conference Paper | |
| 2020 | Trimetazidine in cardiovascular medicine (vol 293, pg 39, 2019) | Marzilli, Mario; ...; Seferovic, Petar M ; (broj, koautora 16) | Other | |
| 2020 | Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association | Mullens, Wilfried; ...; Seferovic, Petar M ; ...; (broj, koautora 29) | Article | |
| 2020 | Heart failure profile in autoimmune diseases, analysis of the Serbian antiphospholipid syndrome patients | Đoković, Aleksandra ; Stojanović, Ljudmila ; Stanisavljević, Nataša S.; Simić, Dragan V. ; Seferović, Petar M. | Conference Paper | |
| 2020 | A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction | Vaduganathan, Muthiah; Jhund, Pardeep S; Claggett, Brian L; Packer, Milton; Widimsky, Jiri; Seferovic, Petar M ; Rizkala, Adel; Lefkowitz, Marty P; Shi, Victor; Mcmurray, John JV;
Solomon, Scott D;
| Article | |
| 2020 | Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) | De, Boer Rudolf A; ...; Seferovic, Petar M ; ...; (broj, koautora 41) | Article | |
| 2020 | Utility of myocardial deformation imaging to reveal potential myocardial fibrosis in patients with clinically suspected myocarditis | Krljanac, Gordana ; Veljić, Ivana ; Ristić, Arsen ; Maksimović, Ružica ; Milinković, Ivan ; Ašanin, Milika ; Nedeljković-Arsenović, Olga ; Polovina, Marija ; Seferović, Petar | Conference Paper | |
Seferović, Petar
